Citi Downgrades Synergy Pharmaceuticals (SGYP) to Neutral
Tweet
Share
E-mailGet Alerts SGYP Hot Sheet
Price: $0.03 --0%
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Citi downgraded Synergy Pharmaceuticals (NASDAQ: SGYP) from Buy to Neutral.
For an analyst ratings summary and ratings history on Synergy Pharmaceuticals click here. For more ratings news on Synergy Pharmaceuticals click here.
Shares of Synergy Pharmaceuticals closed at $6.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Downgrades Legend Biotech Corp. (LEGN) to Perform, 'CEO/Partnership/Competition Overhangs to Cap Upside'
- Nomura/Instinet Downgrades Pearl Abyss Corp. (263750:KS) (BRFS) to Neutral
- Stephens Downgrades Amerant Bancorp Inc (AMTB) to Equal Weight
Create E-mail Alert Related Categories
DowngradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
